Get Premium to unlock powerful stock data
NAS:ANEB (USA)  
Anebulo Pharmaceuticals Inc logo

Anebulo Pharmaceuticals Inc

$ 4.99 +0.76 (+17.97%) 10:08 PM EST
P/E:
At Loss
P/B:
6.79
Market Cap:
$ 116.49M
Enterprise V:
$ 114.22M
Volume:
66.05K
Avg Vol (2M):
9.24K
Also Trade In:
Volume:
66.05K
Market Cap $:
116.49M
PE Ratio:
At Loss
Avg Vol (2-Month):
9.24K
Enterprise Value $:
114.22M
PB Ratio:
6.79
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Anebulo Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
1415 Ranch Road 620 South, Suite 201, Lakeway, TX, USA, 78734
Description
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 1
Interest Coverage No Debt
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 85.4
9-Day RSI 75.6
14-Day RSI 68.32
6-1 Month Momentum % -50
12-1 Month Momentum % -54.89

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 200.56
Quick Ratio 200.56
Cash Ratio 192.42

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -247.36
ROA % -203.34
ROIC % -809.33
ROC (Joel Greenblatt) % -4305.58
ROCE % -206.56

Financials (Next Earnings Date:2022-09-22 Est.)

ANEB's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ANEB

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.79
Beta 0
Volatility % 57.65
14-Day RSI 68.32
14-Day ATR ($) 0.463059
20-Day SMA ($) 3.27838
12-1 Month Momentum % -54.89
52-Week Range ($) 2.67 - 7.885
Shares Outstanding (Mil) 23.34

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Anebulo Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More